These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 22024859)
1. Demographics and treatment trends in sinonasal mucosal melanoma. Gal TJ; Silver N; Huang B Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859 [TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognosis of primary nasal mucosal melanoma--a report of 44 cases]. Peng RQ; Wu GH; Chen WK; Ding Y; Ma J; Zhang NH; Su YS; Zhang XS Ai Zheng; 2006 Oct; 25(10):1284-6. PubMed ID: 17059777 [TBL] [Abstract][Full Text] [Related]
3. Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. Koivunen P; Bäck L; Pukkila M; Laranne J; Kinnunen I; Grénman R; Mäkitie AA Laryngoscope; 2012 Aug; 122(8):1734-8. PubMed ID: 22549303 [TBL] [Abstract][Full Text] [Related]
4. Malignant tumors of the nasal cavity and paranasal sinuses. Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma. Houette A; Gilain L; Mulliez A; Mom T; Saroul N Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):313-317. PubMed ID: 27291483 [TBL] [Abstract][Full Text] [Related]
6. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. McLean N; Tighiouart M; Muller S Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446 [TBL] [Abstract][Full Text] [Related]
7. [Malignant melanomas of the nasal cavity and paranasal sinuses]. Dreher A; Grevers G Laryngorhinootologie; 1995 Feb; 74(2):95-7. PubMed ID: 7710613 [TBL] [Abstract][Full Text] [Related]
8. Mucosal melanoma of the nasal cavity and paranasal sinuses. Gilain L; Houette A; Montalban A; Mom T; Saroul N Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):365-369. PubMed ID: 24906226 [TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718 [TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France. Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L; Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075 [TBL] [Abstract][Full Text] [Related]
12. Effect of surgical modality and hypofractionated split-course radiotherapy on local control and survival from sinonasal mucosal melanoma. Thariat J; Poissonnet G; Marcy PY; Lattes L; Butori C; Guevara N; Dassonville O; Santini J; Bensadoun RJ; Castillo L Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):579-86. PubMed ID: 21621990 [TBL] [Abstract][Full Text] [Related]
13. [Sinonasal mucosal melanoma]. Pomar Blanco P; San Román Carbajo J; Bouso Montero M; Martín Villares C; Fernández Pello M; Tapia Risueño M An Otorrinolaringol Ibero Am; 2007; 34(4):349-58. PubMed ID: 17844954 [TBL] [Abstract][Full Text] [Related]
14. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
15. [Malignant neoplasm of nose and paranasal sinuses in Lower Silesia in years 1992-2001]. Preś K; Pośpiech L; Krecicki T; Nadolska B; Kubacka M; Zatoński T; Jabłonka A; Piechnik-Resler D; Jankowska-Konsur A Wiad Lek; 2006; 59(11-12):797-800. PubMed ID: 17427494 [TBL] [Abstract][Full Text] [Related]
16. Survival rates of sinonasal squamous cell carcinoma with the new AJCC staging system. Lee CH; Hur DG; Roh HJ; Rha KS; Jin HR; Rhee CS; Min YG Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):131-4. PubMed ID: 17309980 [TBL] [Abstract][Full Text] [Related]
17. [The epidemiology and clinical characteristics of malignant melanoma localized in nasal cavity and paranasal sinuses--analysis of 6 cases]. Ziółkowska M; Bień S; Klimas A; Zyłka S Otolaryngol Pol; 2008; 62(4):500-3. PubMed ID: 18837235 [TBL] [Abstract][Full Text] [Related]
18. [Melanoma of the nasal fossae and sinuses, apropos of a series of 7 cases]. Vinel V; Dehesdin D; Marie JP Rev Laryngol Otol Rhinol (Bord); 1990; 111(1):61-5. PubMed ID: 2130402 [TBL] [Abstract][Full Text] [Related]
19. A population-based validation of the American Joint Committee on Cancer melanoma staging system. Gimotty PA; Botbyl J; Soong SJ; Guerry D J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105 [TBL] [Abstract][Full Text] [Related]
20. Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8). Milano AF J Insur Med; 2024 Jul; 51(2):77-91. PubMed ID: 39266003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]